alexa Prashansa Agrawal | The University of Arizona
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Prashansa Agrawal

Prashansa Agrawal Prashansa Agrawal
University of Arizona
USA
Read Interview session with Prashansa Agrawal
Biography

Dr. Prashansha Agrawal is working on anticancer drug targets for quite a couple of years. She has received her PhD degree from Indian Institute of Technology Roorkee, India, where she worked on drug-DNA interaction studies to find out the potential targets for anticancer drugs, which may provide an insight into the rationale for structurally based drug design. After that she joined University of Tennessee as postdoc, where she worked on soluble CD14 (sCD14), which is a serum glycol protein that binds to the Lipid A moiety of lipopolysaccharides (LPS) with high affinity as part of the innate immune response to bacterial endotoxins. Now she has joined University of Arizona and she is working on structure elucidation of DNA G-quadruplex secondary structure that has recently emerged as a new class of cancer-specific molecular targets for cancer therapeutics. Her work is published in peer-reviewed journals and she has been a reviewer for few scientific journals.

Research Interest

Structural biology, computational biology, drug discovery and development, pharmacology, molecular biology, NMR spectroscopy, Chemical Biology, Biophysics, macromolecular interactions

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Regulation of Oncogene Expression via Targeting i-Motif in Nucleic Acids
Prashansa Agrawal
Editorial: J Pharmacovigilance 2017, 5: e165
DOI: 10.4172/2329-6887.1000e165
 
Non-Coding Ribonucleic Acid: A New Anticancer Drug Target
Prashansa Agrawal
Editorial: J Pharmacovigil 2016, 4: e158
DOI: 10.4172/2329-6887.1000e158
 
Potential Prospects of Future Medicine: Nano Medicine
Prashansa Agrawal
Editorial: J Pharmacovigil 2016, 4: e149
DOI: 10.4172/2329-6887.1000e149
 
Advantages and Challenges in Drug Re-Profiling
Prashansa Agrawal
Editorial: J Pharmacovigil 2015, S2:e002
DOI: 10.4172/2329-6887.S2-e002
 
A Focus on Medication Error
Prashansa Agrawal
Editorial: J Pharmacovigilance 2015, S2: e001
DOI: 10.4172/2329-6887.S2-e001
 
Stem Cell Therapy in Drug Discovery and Development
Prashansa Agrawal
Editorial: J Pharmacovigil 2015, 3:e140
DOI: 10.4172/2329-6887.1000e140
 
Recent Advances in Anticancer Drugs Development: G-Quadruplex as New Drug Target
Prashansa Agrawal
Editorial: J Pharmacovigil 2015, 3:e134
DOI: 10.4172/2329-6887.1000e134
 
Significance of Polymers in Drug Delivery System
Prashansa Agrawal
Editorial: J Pharmacovigil 2015, 3:e127
DOI: 10.4172/2329-6887.1000e127
 
Drug Discovery and Development: An Insight into Pharmacovigilance
Prashansa Agrawal
Editorial: J Pharmacovigilance 2014, 2:e120
DOI: 10.4172/2329-6887.1000e120
 
Structure-Based Drug Design
Prashansa Agrawal
Editorial: J Pharmacovigilance 2013, 1: e111
DOI: 10.4172/2329-6887.1000e111
 

Journal of Pharmacovigilance - Structure-based Drug Design


Structure-based Drug Design : Nucleic Acids as anti-cancer drug target

Presented by: Prashansa Agrawal
University of Arizona
USA

 
Download PPT PPT Views: 402 Updated on: 2015-10-20 For Recent Update: Click here
 
 
Download PDF   PDF Views: 402  Updated on: 2015-10-20 For Recent Update: Click here
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords